You're offline — scan, search, vaccines, and full label analysis still work on-device. AI photo OCR and enhancement need a connection.

Skip to main content

Compare Medicines

Compare two medicines side-by-side: halal status, inactive ingredients that differ, and pharmacist questions — free, cited, and private.

Medicine A

Rosuvastatin 10 mg Tablet (generic)

Glenmark Pharmaceuticals
Uncertain
Form
Tablet (film-coated) · 10 mg
Market
US
Confidence
Medium
Inactive ingredients
Open full report
Medicine B

Crestor 10 mg Tablet (Rosuvastatin)

AstraZeneca
Uncertain
Form
Tablet · 10 mg
Market
US
Confidence
Medium
Inactive ingredients
Open full report

Comparison summary

Rosuvastatin 10 mg Tablet (generic) is Uncertain with Medium confidence. Crestor 10 mg Tablet (Rosuvastatin) is Uncertain with Medium confidence. They share 6 inactive ingredients in our database and differ on 0 others.

Similar halal profiles in our database — open each medicine below for other formulations and ranked alternatives.

Inactive ingredient differences

6 shared · 0 only in Rosuvastatin 10 mg Tablet (generic) · 0 only in Crestor 10 mg Tablet (Rosuvastatin)

Shared ingredients (6) appear in both products — open each medicine report for the full list.

Questions about this comparison

How do Rosuvastatin 10 mg Tablet (generic) and Crestor 10 mg Tablet (Rosuvastatin) compare for halal status?
Rosuvastatin 10 mg Tablet (generic): Uncertain (Medium confidence). Crestor 10 mg Tablet (Rosuvastatin): Uncertain (Medium confidence). RxHalal does not issue religious rulings — use this to ask your pharmacist about sources.
Which inactive ingredients differ between these two medicines?
All 6 tracked inactive ingredients appear in both products.
What should I ask my pharmacist when comparing these medicines?
Is the stearate plant-derived?
Is Crestor 10 mg Tablet (Rosuvastatin) a halal-friendlier option than Rosuvastatin 10 mg Tablet (generic)?
In our database, Crestor 10 mg Tablet (Rosuvastatin) ranks cleaner (Listed alternate formulation — same active, different excipients or dosage form.). Confirm equivalence and dosing with your clinician — not a fatwa.

Clinician-friendly share summary

A neutral 6–10 line summary you can paste into a message or print.

Letter for ALetter for B